Albumin oxidation leads to neutrophil activation in vitro and inaccurate measurement of serum albumin in patients with diabetic nephropathy

Free Radical Biology and Medicine

Volumn 60, Issue , 2013, Pages 49-55

  Michelis, Regina ^a   Kristal, Batya ^a,b   Zeitun, Teuta ^a   Shapiro, Galina ^a   Fridman, Yoav ^a   Geron, Ronit ^a   Sela, Shifra ^a,b  

^a WESTERN GALILEE HOSPITAL   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

Albumin; Free radicals; Glycoxidation; Hypoalbuminemia; MPO; Neutrophils; NGAL

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INTERLEUKIN 6; MYELOPEROXIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALBUMIN BLOOD LEVEL; ALBUMIN DETECTION INDEX; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME RELEASE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPOALBUMINEMIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY FUNCTION; LEUKOCYTE ACTIVATION; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA;

ADULT; AGED; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPOALBUMINEMIA; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; OXIDATION-REDUCTION; SERUM ALBUMIN;

EID: 84874940935     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.02.005     Document Type: Article

References (43)

1. R. Michelis, B. Kristal, T. Snitkovsky, and S. Sela Oxidative modifications impair albumin quantification Biochem. Biophys. Res. Commun. 401 2010 137 142
2. H.Z. Pan, L. Zhang, M.Y. Guo, H. Sui, H. Li, W.H. Wu, N.Q. Qu, M.H. Liang, and D. Chang The oxidative stress status in diabetes mellitus and diabetic nephropathy Acta Diabetol. 47 Suppl. 1 2010 71 76
3. A. Piwowar, M. Knapik-Kordecka, and M. Warwas Markers of oxidative protein damage in plasma and urine of type 2 diabetic patients Br. J. Biomed. Sci. 66 2009 194 199
4. A. Piwowar, M. Knapik-Kordecka, and M. Warwas Comparison of the usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients Clin. Invest. Med 33 2010 E109
5. A.A. Elmarakby, and J.C. Sullivan Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy Cardiovasc. Ther. 30 2012 49 59
6. F. Galli Protein damage and inflammation in uraemia and dialysis patients Nephrol. Dial. Transplant. 22 Suppl. 5 2007 v20 36
7. R. Shurtz-Swirski, S. Sela, A.T. Herskovits, S.M. Shasha, G. Shapiro, L. Nasser, and B. Kristal Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients Diabetes Care 24 2001 104 110
8. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ. Res. 107 2010 1058 1070
9. M.P. Cohen, and F.N. Ziyadeh Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy J. Am. Soc. Nephrol. 7 1996 183 190
10. T. Miyata, and C.Y. de Strihou Diabetic nephropathy: a disorder of oxygen metabolism? Nat. Rev. Nephrol 6 2010 83 95
11. Y. Chen, C.P. Liu, K.F. Xu, X.D. Mao, Y.B. Lu, L. Fang, J.W. Yang, and C. Liu Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advanced glycation end products in cultured mouse podocytes Am. J. Nephrol. 28 2008 1014 1022
12. A. Watanabe, Y. Tomino, K. Yokoyama, and H. Koide Production of hydrogen peroxide by neutrophilic polymorphonuclear leukocytes in patients with diabetic nephropathy J. Clin. Lab. Anal. 7 1993 209 213
13. S. Sela, R. Shurtz-Swirski, M. Cohen-Mazor, R. Mazor, J. Chezar, G. Shapiro, K. Hassan, G. Shkolnik, R. Geron, and B. Kristal Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease J. Am. Soc. Nephrol. 16 2005 2431 2438
14. D. Bolignano, A. Lacquaniti, G. Coppolino, V. Donato, S. Campo, M.R Fazio, G. Nicocia, and M. Buemi Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease Clin. J. Am. Soc. Nephrol. 4 2009 337 344
15. J. Malyszko, H. Bachorzewska-Gajewska, E. Sitniewska, J.S. Malyszko, B. Poniatowski, and S. Dobrzycki Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease Renal Failure 30 2008 625 628
16. Y.H. Yang, X.J. He, S.R. Chen, L. Wang, E.M. Li, and L.Y. Xu Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study Endocrine 36 2009 45 51
17. J. Malyszko, J.S. Malyszko, E. Koc-Zorawska, P. Kozminski, and M. Mysliwiec Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation Kidney Blood Press. Res 32 2009 464 469
18. G. Eknoyan, T. Hostetter, G.L. Bakris, L. Hebert, A.S. Levey, H.H. Parving, M.W. Steffes, and R. Toto Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Am. J. Kidney Dis. 42 2003 617 622
19. G. Münch, R. Keis, A. Wessels, P. Riederer, U. Bahner, A. Heidland, T. Niwa, H.D. Lemke, and R. Schinzel Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA Eur. J. Clin. Chem. Clin. Biochem. 35 1997 669 677
20. D.A. Partrick, E.E. Moore, F.A. Moore, C.C. Barnett, and C.C. Silliman Lipid mediators up-regulate CD11b and prime for concordant superoxide and elastase release in human neutrophils J. Trauma 43 1997 297 302 discussion 302-303
21. L. Kjeldsen, D.F. Bainton, H. Sengeløv, and N. Borregaard Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils Blood 83 1994 799 807
22. P. Rondeau, and E. Bourdon The glycation of albumin: structural and functional impacts Biochimie 93 2011 645 658
23. J. Himmelfarb, and E. McMonagle Albumin is the major plasma protein target of oxidant stress in uremia Kidney Int 60 2001 358 363
24. P.S. Lim, Y.M. Cheng, and S.M. Yang Impairments of the biological properties of serum albumin in patients on haemodialysis Nephrology 12 2007 18 24
25. K. Mera, M. Anraku, K. Kitamura, K. Nakajou, T. Maruyama, K. Tomita, and M. Otagiri Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients Hypertens. Res. 28 2005 973 980
26. Z.M. Bian, V.M. Elner, N.W. Lukacs, R.M. Strieter, S.L. Kunkel, and S.G. Elner Glycated human serum albumin induces IL-8 and MCP-1 gene expression in human corneal keratocytes Curr. Eye Res. 17 1998 65 72
27. W. Liu, G.Z. Xu, C.H. Jiang, and J. Tian Macrophage colony-stimulating factor and its receptor signaling augment glycated albumin-induced retinal microglial inflammation in vitro BMC Cell Biol 12 2011 5
28. N. Thongtang, M. Ai, S. Otokozawa, T.V. Himbergen, B.F. Asztalos, K. Nakajima, E. Stein, P.H. Jones, and E.J. Schaefer Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation Am. J. Cardiol. 107 2011 387 392
29. S. Hattori Sitagliptin reduces albuminuria in patients with type 2 diabetes Endocr. J. 58 2011 69 73
30. C. Jin, L. Lu, R.Y. Zhang, Q. Zhang, F.H. Ding, Q.J. Chen, and W.F. Shen Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus Clin. Chim. Acta 408 2009 45 49
31. M. Kaefer, S.J. Piva, J.A. De Carvalho, D.B. Da Silva, A.M. Becker, A.C. Coelho, M.M. Duarte, and R.N. Moresco Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus Clin. Biochem. 43 2010 450 454
32. A. Watanabe, Y. Tomino, K. Yokoyama, and H. Koide Production of hydrogen peroxide by neutrophilic polymorphonuclear leukocytes in patients with diabetic nephropathy J. Clin. Lab. Anal. 7 1993 209 213
33. R.K. Wong, A.I. Pettit, P.A. Quinn, S.C. Jennings, J.E. Davies, and L.L. Ng Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic Acid Circulation 108 2003 1858 1864
34. D. Bolignano, A. Lacquaniti, G. Coppolino, V. Donato, M.R. Fazio, G. Nicocia, and M. Buemi Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients Kidney Blood Press. Res 32 2009 91 98
35. K. Omori, T. Ohira, Y. Uchida, S. Ayilavarapu, E.L. Batista Jr, M. Yagi, T. Iwata, H. Liu, H. Hasturk, A. Kantarci, and T.E. Van Dyke Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase J. Leukocyte Biol. 84 2008 292 301
36. R.K. Schindhelm, L.P. van der Zwan, T. Teerlink, and P.G. Scheffer Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? Clin. Chem 55 2009 1462 1470
37. G.A. Kaysen al Bander, H. Metabolism of albumin and immunoglobulins in the nephrotic syndrome Am. J. Nephrol 10 Suppl. 1 1990 36 42
38. M. Chojkier Inhibition of albumin synthesis in chronic diseases: molecular mechanisms J. Clin. Gastroenterol 39 Suppl. 2 2005 S143 146
39. G. Rashid, S. Benchetrit, D. Fishman, and J. Bernheim Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells Kidney Int 66 2004 1099 1106
40. N. Ahmed Advanced glycation endproducts - role in pathology of diabetic complications Diabetes Res. Clin. Pract 67 2005 3 21
41. K. Iseki, N. Kawazoe, and K. Fukiyama Serum albumin is a strong predictor of death in chronic dialysis patients Kidney Int. 44 1993 115 119
42. K. Kalantar-Zadeh, J.D. Kopple, G. Block, and M.H. Humphreys A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients Am. J. Kidney Dis. 38 2001 1251 1263
43. N.R. Shah, and F. Dumler Hypoalbuminaemia - a marker of cardiovascular disease in patients with chronic kidney disease stages II-IV Int. J. Med. Sci. 5 2008 366 370